Related Experiment Video
Updated: Feb 15, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
TAp63 is correlated with chronic inflammation in patients with newly diagnosed type 2 diabetes mellitus
1Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Aims:
To investigate TAp63 expression in patients with type 2 diabetes mellitus (T2DM) and the potential correlations between TAp63 and proinflammatory cytokines production and other clinical parameters.
Methods:
Peripheral blood mononuclear cells (PBMCs) and plasma were collected from 72 T2DM (cases) and 72 healthy subjects (controls). Fasting blood glucose (FBG), fasting insulin (FIN) and a blood lipid profile were measured. The homeostasis model assessment (HOMA) was used to estimate insulin resistance (IR). Plasma tumor necrosis factor-α (TNF-α) and interleukin (IL)-6 were determined. PBMCs isolated from healthy subjects were cultured with or without 33.3 mmol/l glucose or 0.5 mmol/l palmitic acid (PA) for 6 h, 24 h, 48 h, and 72 h. The expression of TAp63 at mRNA and protein levels in PBMCs was analyzed using real-time qRT-PCR and western blots, respectively.
Results:
TAp63 expression was significantly lower in T2DM patients compared with that of the controls. In addition, TAp63 expression showed a negative correlation with FBG, FIN, HbA1c, HOMA-IR, FFAs, TNF-α, and IL-6 levels. Treatment with 33.3 mmol/l glucose or 0.5 mmol/l PA increased TAp63 expression in the cultured PBMCs.
Conclusions:
TAp63 level may be correlated with chronic inflammatory state and perturbed glucose and lipid metabolism in T2DM.
Insights
TAp63 expression is lower in type 2 diabetes mellitus (T2DM) patients and correlates negatively with inflammation and metabolic dysfunction. Glucose and palmitic acid treatments increased TAp63 levels in cells.
Area of Science:
- Endocrinology
- Molecular Biology
- Immunology
Background:
- Type 2 Diabetes Mellitus (T2DM) is a complex metabolic disorder characterized by chronic inflammation and impaired glucose and lipid metabolism.
- The role of TAp63, a p53 family member, in the pathogenesis of T2DM remains largely unexplored.
Purpose of the Study:
- To investigate TAp63 expression in patients with T2DM.
- To explore the correlation between TAp63 levels, proinflammatory cytokines, and clinical parameters in T2DM.
- To examine the effect of high glucose and palmitic acid on TAp63 expression in vitro.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) and plasma were collected from 72 T2DM patients and 72 healthy controls.
- Clinical parameters, insulin resistance (HOMA-IR), and plasma levels of TNF-α and IL-6 were assessed.
- TAp63 expression in PBMCs was analyzed via qRT-PCR and Western blot, and its response to glucose and palmitic acid in cultured PBMCs was evaluated.
Main Results:
- TAp63 expression was significantly lower in T2DM patients compared to controls.
- TAp63 expression negatively correlated with fasting blood glucose (FBG), fasting insulin (FIN), HbA1c, HOMA-IR, free fatty acids (FFAs), TNF-α, and IL-6.
- In vitro, treatment with high glucose or palmitic acid increased TAp63 expression in PBMCs.
Conclusions:
- TAp63 levels may be associated with the chronic inflammatory state observed in T2DM.
- Perturbed glucose and lipid metabolism in T2DM might be linked to altered TAp63 expression.
- TAp63 warrants further investigation as a potential biomarker or therapeutic target in T2DM.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Inflammation
Correlations
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...

